| Skin and Soft Tissue Infection |
1 |
1 |
| Otolaryngology |
0 |
0.96 |
| Pediatric Respiratory Infections |
0 |
0.85 |
| Fever |
0 |
0.73 |
| Scarlet Fever |
0 |
0.99 |
| Measles |
0 |
0.43 |
| Fatigue |
0 |
0.3 |
| Pain Management |
0 |
0.29 |
| Child |
0 |
0.98 |
| Erythema Infectiosum |
0 |
0.24 |
| Antibiotics |
0 |
0.19 |
| Tuberculosis |
0 |
0.19 |
| Roseola Infantum |
0 |
0.18 |
| Influenza |
0 |
0.15 |
| Acute Pharyngitis |
0 |
0.13 |
| Strep Throat |
0 |
0.13 |
| Buccal Region |
0 |
0.12 |
| Cough |
0 |
0.12 |
| Face |
0 |
0.12 |
| Pharyngitis |
0 |
0.12 |
| Trunk |
0 |
0.12 |
| Cornea and External Disease |
0 |
0.09 |
| Diarrhea |
0 |
0.09 |
| Headache |
0 |
0.09 |
| Revenue and Practice Management |
0 |
0.09 |
| Rhinorrhea |
0 |
0.09 |
| Vaccines |
0 |
0.09 |
| Adolescent Medicine |
0 |
0.06 |
| Antihistamine |
0 |
0.06 |
| Bacteria |
0 |
0.06 |
| Board Certification |
0 |
0.06 |
| Conjunctivitis |
0 |
0.06 |
| Human Herpesvirus 6 (HHV-6) |
0 |
0.06 |
| Mouth |
0 |
0.06 |
| Nausea |
0 |
0.06 |
| Nonsteroidal Anti-Inflammatory Agents |
0 |
0.06 |
| Nose |
0 |
0.06 |
| Private Practice |
0 |
0.06 |
| Prognosis |
0 |
0.06 |
| Pruritus |
0 |
0.06 |